Infectious Diseases Archive — Page 8 of 13
-
August 16, 2022
Q&A: Reassurance for parents on mpox risk, spread and symptoms
A pediatric infectious diseases expert answers questions parents might have about the risk of mpox risk to children. -
August 4, 2022
Study tracks limited use of influenza antiviral therapy
A Vanderbilt study found that more than half of children diagnosed with influenza and deemed high risk for flu-related complications were given the recommended antiviral treatment. -
July 21, 2022
Study explores role RSV plays in later asthma development
A Vanderbilt clinical project will follow 1,950 Middle Tennessee children to determine how genes and the environment interact with RSV infection during the first year of life and contribute to asthma development -
June 2, 2022
Bacterial battle in 3D
Using imaging mass spectrometry and microscopy, Vanderbilt researchers visualized how staph bacteria modifies lipids in its membrane to evade immune system-mediated killing. -
May 5, 2022
VUMC team discovers how bacterial pathogen survives without water
Vanderbilt researchers are studying a bacterial pathogen that can survive on hospital surfaces — without water — for months, an ability that has helped it become a leading cause of hospital-acquired infections. -
April 7, 2022
Study advances understanding of bacterial bioterrorism agent
Vanderbilt researchers have identified a critical regulatory factor in the bacterium that causes the disease anthrax and has been used as a biological weapon. -
March 17, 2022
Study compares kidney injury risk for COVID, flu patients
A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.